Newspapers in Tucson and Phoenix included articles Oct. 18 on a two-state collaboration of health care specialists for an NIH randomized clinical trial for treating Valley Fever and efforts to develop a vaccine that are led by researchers at the University of Arizona College of Medicine – Tucson.
You can read the articles here:
Frank Porreca, PhD, associate head of the Department of Pharmacology at the University of Arizona College of Medicine – Tucson, has been honored by the International Association for the Study of Pain (IASP) with the Ronald Melzack Lecture Award.
A 12-year study led by a team of University of Arizona Cancer Center researchers is bringing into question the safety and efficacy of selenium, a popular nutritional supplement touted to combat and reduce the risk of colorectal cancer.
The findings indicate the need for a significant change in practice, given that selenium supplements cannot be recommended for preventing colorectal cancer.
The Petersen HIV Clinics Pharmacy Group is providing a presentation on “Are Long Term Side Effects Going Extinct?” at its next meet-your-pharmacist community event under the playful heading “T-Rx Group (Team Rx)” with a Jurassic-Park-like theme logo.
David Raichlen, PhD, an associate professor and research scientist in the UA School of Anthropology, will be the next speaker for the UA Endocrinology Grand Rounds.
Susan G. Komen, the Milburn Foundation, and the Inflammatory Breast Cancer Research Foundation have entered into a groundbreaking partnership to provide a unique funding opportunity addressing key needs in this understudied form of breast cancer.
They are now accepting requests for applications, or requests for proposals (RFPs), for research funding of up to $60,000 for one year.
David G.
Recognized for its commitment to diversity and inclusion in the health professions, the University of Arizona College of Medicine – Tucson has been honored with INSIGHT Into Diversity magazine’s 2016 Health Professions Higher Education Excellence in Diversity (HEED) Award.
The most challenging diseases require a multidisciplinary approach for research and treatment.
University of Arizona professor of surgery David G. Armstrong, DPM, MD, PhD, shared the potential and his lab’s current use of 3-D printing in medicine in a recently published article in The Lancet.
